Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$581,723
+$135,635 QoQ
Shares Held
485
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#3,621
of 4,605 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Capital, Inc. holds $113,799,273 across 8 Drug Manufacturers - General names. LLY ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
154,756 | $38,942,799 | |
| 2 | AMGN |
Amgen Inc
|
90,924 | $32,925,398 | |
| 3 | JNJ |
Johnson & Johnson
|
115,036 | $29,215,692 | |
| 4 | PFE |
Pfizer Inc
|
267,909 | $6,451,248 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
36,158 | $4,568,201 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,642 | $596,497 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
485 | $581,723 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,985 | $517,715 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $581,723 | 485 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $446,088 | 485 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $521,219 | 485 | Shares | Sole | 2026-02-12 | |
| 2025-03-31 | $202,347 | 245 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||